2024
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention
Park D, Hu J, Jamil Y, Kelsey M, Jones W, Frampton J, Kochar A, Aronow W, Damluji A, Nanna M. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention. JAMA Network Open 2024, 7: e244000. PMID: 38546647, PMCID: PMC10979312, DOI: 10.1001/jamanetworkopen.2024.4000.Peer-Reviewed Original ResearchConceptsOlder adultsMonths of DAPTDuration of dual antiplatelet therapySystematic reviewRandomized clinical trialsPercutaneous coronary interventionMeta-analysisPreferred Reporting ItemsAssess data qualityRisk of bleedingDuration of DAPTDual antiplatelet therapyWeb of ScienceMain OutcomesReporting ItemsData extractionAbstracted dataSecondary outcomesRisk ratioAntiplatelet therapyPrimary outcomeCochrane LibraryCoronary interventionReference groupNetwork meta-analysis
2022
Abbreviated versus Standard Duration of DAPT after PCI: A Systematic Review and Network Meta-analysis
Park D, An S, Kumar A, Malhotra S, Jolly N, Kaur A, Kattoor A, Doukky R, Kalra A, Vij A. Abbreviated versus Standard Duration of DAPT after PCI: A Systematic Review and Network Meta-analysis. American Journal Of Cardiovascular Drugs 2022, 22: 633-645. PMID: 35781867, DOI: 10.1007/s40256-022-00541-w.Peer-Reviewed Original ResearchConceptsNet adverse clinical eventsDuration of DAPTPercutaneous coronary interventionNetwork meta-analysisShorter duration of DAPTStent thrombosisMyocardial infarctionDrug-eluting stentsMeta-analysisResultsSeventeen randomized controlled trialsSystematic reviewAdverse cardiac eventsAdverse clinical eventsFrequentist network meta-analysesRisk of myocardial infarctionBackgroundDual antiplatelet therapyMonths of DAPTRandomized controlled trialsRandom-effects modelNetwork meta-analysesClinical presentationNo significant differenceAntiplatelet therapyMethodsThe present studyCardiac eventsFactor Xa Inhibitors Versus Vitamin K Antagonist in Morbidly Obese Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis
Park D, An S, Arif A, Vij A. Factor Xa Inhibitors Versus Vitamin K Antagonist in Morbidly Obese Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine 2022, 40: 82-83. DOI: 10.1016/j.carrev.2022.06.184.Peer-Reviewed Original ResearchShortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis
Park DY, Wang P, An S, Grimshaw AA, Frampton J, Ohman EM, Rao SV, Nanna MG. Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis. American Heart Journal 2022, 251: 101-114. PMID: 35654162, PMCID: PMC10904033, DOI: 10.1016/j.ahj.2022.05.019.Peer-Reviewed Original ResearchConceptsMonths of DAPTHazard ratioIschemic eventsDuration of DAPTSelect patient characteristicsDual antiplatelet therapyAcute coronary syndromeCoronary artery lesionsPercutaneous coronary interventionConfidence intervalsAssociation of outcomesRandom-effects modelComprehensive literature searchMeta-regression analysisMajor bleedingAntiplatelet therapyCoronary syndromeArtery lesionsCoronary interventionControlled TrialsPatient characteristicsPrespecified outcomesGreater proportionSimilar efficacySystematic reviewIncidence and risk factors of atrial fibrillation and atrial arrhythmias in people living with HIV: a systematic review and meta-analysis
Park D, An S, Romero M, Kaur A, Ravi V, Huang H, Vij A. Incidence and risk factors of atrial fibrillation and atrial arrhythmias in people living with HIV: a systematic review and meta-analysis. Journal Of Interventional Cardiac Electrophysiology 2022, 65: 183-191. PMID: 35610524, DOI: 10.1007/s10840-022-01233-w.Peer-Reviewed Original ResearchConceptsRisk of atrial arrhythmiasAtrial arrhythmiasRisk factorsIncidence rateHIV infectionManaging cardiovascular risk factorsAssociated with decreased riskEfficacious antiretroviral therapyAtrial fibrillationMeta-Analysis guidelinesBurden of atrial arrhythmiasRisk factors of atrial fibrillationIncreased risk of atrial arrhythmiasTreatment of HIV infectionCardiovascular risk factorsRandom-effects modelCases of atrial arrhythmiasPotential risk factorsBackgroundCardiovascular diseaseIncreased viral loadPooled summary statisticsIncreasing burdenData extractionGeneral populationSystematic reviewEffect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis
Park D, An S, Murthi M, Kattoor A, Kaur A, Ravi V, Huang H, Vij A. Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis. Journal Of Interventional Cardiac Electrophysiology 2022, 64: 763-771. PMID: 35258752, DOI: 10.1007/s10840-022-01168-2.Peer-Reviewed Original ResearchConceptsRecurrence of AFStudy of patientsHistory of AFAblation therapyAtrial fibrillationWeight lossRate of recurrence of AFSubgroup analysisRecurrence of atrial fibrillationRisk ratioEffects of weight lossSubgroup analysis of studiesLong-term recurrenceLost weightWeight loss groupMethodsAn extensive literature searchSystematic reviewStudies of weight lossConclusionWeight lossLow recurrenceMedical therapyLoss groupResultsEight studiesRecurrenceTherapyCRT-500.16 Factor Xa Inhibitors Versus Vitamin K Antagonist in Morbidly Obese Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis
Park D, An S, Arif A, Vij A. CRT-500.16 Factor Xa Inhibitors Versus Vitamin K Antagonist in Morbidly Obese Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis. JACC Cardiovascular Interventions 2022, 15: s49. DOI: 10.1016/j.jcin.2022.01.203.Peer-Reviewed Original Research